Nutritional Considerations in Failure to Thrive

Back

Practice Essentials

Failure to thrive is an interruption in the normal pattern of growth, usually seen in younger children. While many anthropometric standards have been employed to define "growth," (BMI, weight, or weight-for-height z-scores), serially comparing a child to appropriate standard growth curves is now commonly employed. 

Often exacerbating the effects of chronic infections, failure to thrive is perhaps the greatest contributor to worldwide childhood morbidity and mortality. Stunting with intellectual compromise is seen in children who survive long periods of inadequate growth. In the developed world, there is controversy regarding the long-term deficits seen in children who experience failure to thrive. However, the contribution that failure to thrive plays in contributing to the morbidity of pediatric pathologic states is being more appreciated.  

Failure to thrive can be secondary to inadequate intake of calories, inefficient utilization of ingested calories (emesis, malabsorption) or an increased basal metabolism (usually seen in oncology, infections, cardiopulmonary deficiencies, chronic inflammatory states, and hyperthyroidism). 

Comprehensive evaluation of children by multidisciplinary feeding teams has illustrated that frequently more than one entity is present in a single child with failure to thrive. One example would be the anorexia related to depression seen in children with chronic illnesses.

It has been long considered dogma that the overwhelming majority of children with growth impairment in the developing world have psychosocial issues that result in nonorganic failure to thrive. Multiple feeding teams have noted that among children with nonorganic failure to thrive, there is frequently a subtle organic problem such as dysphagia, gastroesophageal reflux, constipation, or food allergy/intolerance that has created pain and/or fear in this cohort. Recognition and therapy that addresses these issues have yielded improved outcomes.     

Background

Failure to thrive (FTT) is both a descriptive term for various entities and a diagnosis. It is defined as a significant interruption in the expected rate of growth during early childhood. Because sequential measurements of growth are vital aspects of preventive pediatrics, FTT is a concern for all pediatric heath care providers. All standard pediatric textbooks have sections on this topic,[1] and numerous review articles have been written.[2, 3, 4, 5, 6] However, despite significant attention, the consequences of FTT on developmental outcomes in industrialized children is controversial as discussed in the section on prognosis below. It is easier to appreciate that in certain children, FTT can be a prelude to significant physical and cognitive morbidity, including stunting, and mortality. This is especially relevant throughout the developing world, in rural and impoverished inner city children, and in those with multiple chronic illnesses. Two significant developments in the approach to the child with FTT have begun to dramatically influence the approach to these children.

Firstly, while it is accepted that all children with failure to thrive have inadequate or worsening growth over time, one area of controversy is determining which anthropometric criteria should be utilized to define this term.[7] The most common definitions are weight less than the third to fifth percentile for age on more than one occasion or weight measurements that fall 2 major percentile lines using the standard growth charts of the National Center for Health Statistics (NCHS).

Some authors have included height measurements as part of the definition; however, height measurements more precisely describe short stature. If weight parameters are significantly compromised, height can also be secondarily affected in individuals with FTT. A European study examined a large cohort of children using various terms associated with pediatric growth compromise and documented a wide variance in the prevalence of this condition.[8] Although serial measurements of head circumference are important in the evaluation of infants and toddlers, isolated failure of the head to grow should not suggest the typical failure to thrive differential.

The American Society for Parenteral and Enteral Nutrition assembled a group of experts that recently published a comprehensive report on pediatric malnutrition based on a comprehensive analysis of literature published through 2011.[9] They organized their review, discussion, recommendations and definition around five key domains. The authors developed a novel definition of pediatric malnutrition that clearly overlaps with the term failure to thrive as employed in this article and by multiple other authors. Their proposed definition is an “imbalance between nutrient requirements and intake, resulting in cumulative deficits of energy, protein, or micronutrients that may negatively affect growth, development, and other relevant outcomes."

To address the controversy of determining which anthropometric criteria should be utilized to define FTT, the group has recommended that z-scores be used to express individual anthropometric variables in relation to the population reference standard. The authors agree that this is the best approach to track serial measurements in a child being evaluated for FTT.

The second new development in the approach to a child with FTT is that especially since 2011, there have been a number of publications from multidisciplinary feeding groups from around the United States that have stressed the significant integration between physical issues and psychosocial problems that yield FTT (see pathophysiology section below).

The working group characterized failure to thrive as “a term used to describe children who are not growing as expected.” They note that more than 90% of cases in most studies do not have an underlying medical cause, and virtually all are identified by a careful history and physical exam.[10] The report also cites a paper describing an inner city academic center that only evaluated 75 children in their specialized clinics over a 40 month period. These authors and others have characterized virtually all of their referrals as having psychosocial etiologies for their FTT and recommended a reappraisal of how to provide resources for these children.[11]

Another recent study from a multidisciplinary feeding program at a US medical school also reports that 90% of their referrals had nonorganic failure to thrive. While they described a very short follow-up, they also report that children who adhered to their basic instructions were able to quickly gain significantly more weight than those were “nonadherent.” However, the 25% of the cohort who were unable to follow directions, may also include children who had unidentified issues.[12]

With the routine inclusion of comprehensive speech and feeding evaluations as part of the FTT work-up, psychosocial compromise is now recognized as most likely to yield failure to thrive in children with subtle swallowing dysfunction, or other primary organic conditions, especially those associated with visceral pain during feeds.[13] As this fundamental paradigm is reconsidered,[14, 15] the practicing provider evaluating a deprived child with failure to thrive must make every effort to illicit and correct discomfort (such as feeding refusal, grimacing, bloating, premature satiety) or dysphagia (such as coughing, choking, gagging, or extended meal times). Thus, a routine part of the evaluation of children with failure to thrive is identifying any pathophysiologic conditions that may contributing factors.  

To consolidate all of these nuances, some authors have gone from categorizing children as either one extreme or the other to describing a spectrum extending from pure nonorganic failure to thrive to pure organic failure to thrive, with individual children lying closer to one or the other.[16] In this view, medical, developmental, neurological, environmental issues are often found in a single child.[17]

Normal growth and growth charts of term and premature infants, as well as the etiology, evaluation, management, and outcome of failure to thrive are discussed in this article. For information on energy malnutrition, see the article Marasmus.

Pathophysiology

Organic FTT is secondary to inadequate intake, increased losses, compromised utilization of ingested calories, excessive metabolic demands, or combinations of these factors. Nonorganic failure to thrive is defined as a consequence of inadequate energy intake. However, the complexity of inadequate intake has now been studied in more detail. While classically viewed as a behavioral i.e. nonorganic problem, it is now appreciated that identifiable and treatable pathologies can be antecedents of this behavior and must be eradicated to reverse this situation.[18] Conversely, the increased prevalence of FTT in children with chronic medical conditions has been emphasized by the recent pediatric malnutrition working group which recommended that malnutrition be characterized explicitly with reference to the specific pathologic state.[9] The following examples illustrate the spectrum of potential interactions between organic and nonorganic features in FTT children.[19, 20, 21, 22, 23, 24, 25]

Factors contributing to childhood feeding difficulties were described in 340 out of 349 participants identified by an interdisciplinary feeding team. These included developmental disabilities, gastrointestinal problems, cardiopulmonary problems, neurological problems, renal disease and anatomical anomalies. The most prevalent condition was gastroesophageal reflux.[19]

In a review of 38 intervention studies of 218 children with food refusal, 212 had some form of a medical issue. The majority, 116 children (55%), had gastrointestinal disorders (e.g. gastroesophageal reflux) and 131 (62%) had a non-gastrointestinal medical disorder (e.g. bronchopulmonary dysplasia, seizure disorder). In this study  gastroesophageal reflux was the most common medical diagnosis while other diagnoses such as cardiopulmonary conditions (33%), neurological conditions (25%), food allergies (15%) anatomical anomalies (14%) and delayed gastric emptying (6%) were also reported.[20]

Another study examining sensory processing skills in a childhood feeding disorders group of toddlers with nonorganic failure to thrive concluded that sensory processing problems were more commonly observed in toddlers with feeding problems and growth deficiency.[21]

Out of a 143 subjects in a feeding clinic in a tertiary hospital, 65.5% (55/84) of children with a medical condition also had one or more feeding behavior disorders. This study by Jung et al also found no underlying medical disorder to explain the feeding disorders in 59 (41.3%) of the 143 subjects. Many of these children had feeding behavior disorders such as sensory food aversion and infantile anorexia with FTT.[22]

Dysphagia or odynophagia, caused by the inflammation of the esophagus (drug-induced, allergic, eosinophilic or induced by gastroesophageal reflux disease), motor dysfunction or structural anomaly of the upper gastrointestinal tract, is well recognized as a cause of food refusal as swallowing food becomes a triggering factor of pain.[23, 24]

In a study characterizing the feeding difficulty of 700 children referred for assessment of severe feeding difficulty, close to 50% of the children had a combined medical and oral condition underlying their feeding difficulties. More than half of the children were examined for gastrointestinal conditions, particularly gastroesophageal reflux disease. The results indicate that oral sensory-based feeding problems are related to past medical intervention.[25]

Normal growth in term infants

The average birth weight for a term infant is 3.3 kg. Weight drops as much as 10% in the first few days of life, secondary to loss of excess fluid. By 10-14 days of life, birth weight should be regained. Breastfed infants who are fed smaller volumes of colostrum for the first few days regain birth weight a little later than bottle-fed infants.

On average, infants gain 1 kg/mo for the first 3 months, 0.5 kg/mo from age 3-6 months, 0.33 kg/mo from age 6-9 months, and 0.25 kg/mo from age 9-12 months.  Expressed in another perspective, full term infants double their birth weight by 4-6 months of age and triple their weight by 12 months of age. A third approach to use is that term infants gain almost 30 g (1 oz) per day for 3 months and then almost 15 g (0.5 oz) per day for the next 6 months. From 9 months of age until the child is a toddler, the average weight gain is roughly 0.25 kg/mo (or 0.5 lb/mo). Afterwards, the weight gain is about 2 kg/y through early school age.

Caloric requirements to assure adequate intake in a normal infant is 100-110 kcal/kg/d for the first six months and decreases slightly to 100 kcal/kg/d for the second half of the first year. Beyond 10 kg, 50 kcal/kg/day is required until 20 kg and beyond 20 kg, 20 kcal/kg/d are necessary.

Term infants grow 25 cm in length during the first year, 12.5 cm in the second year, and then slow down to approximately 5-6 cm between 4 years of age and the onset of puberty, at which time, growth can increase up to 12 cm per year.

The average head circumference is 35 cm at birth and rapidly increases to 47 cm by age 1 year. The rate of growth then slows, reaching an average of 55 cm by 6 years of age.

Also, the upper-to-lower body segment ratio changes with growth. Normally, the ratio at birth is 1.7, the ratio at 3 years of age is 1.3, and the ratio by 7 years of age becomes 1.0 with the upper body segment and lower body segment being about equal. The lower body segment is measured from the symphysis pubis to the floor.

Normal growth in premature infants

When plotting growth charts for premature babies, a "corrected age" should be used. This corrected age can be calculated by subtracting the number of weeks of prematurity from the postnatal age. Special growth charts based on gestational age rather than chronological age have been developed for infants, beginning at 26 weeks' gestational age. However, because these charts represent a compilation of a relatively small number of infants, they may not be completely reliable. Whichever technique is used for premature babies (eg, adjustment of age, using specific premature growth charts), consistency of methodology is essential. Once a method for plotting growth is chosen, that technique should be followed each time plotting occurs. Prior to 40 weeks' gestation, some infants may require as much as 120 kcal/kg/d to ensure adequate weight gain.

Catch-up growth is attained at approximately 18 months of age for head circumference, 24 months of age for weight, 40 months of age for height. Subsequently, normal growth charts can be used. In some premature babies with very low birth-weight, catch-up growth does not occur until early school age.

Growth charts

Growth charts were developed by the NCHS based on data collected through the Third National Health and Nutrition Examination Survey. They have been used since 1977 and are available for males and females 0-36 months of age and 2-18 years of age. The growth charts for boys and girls 0-36 months of age include weight and height for age and head circumference; growth charts for both age groups include weight for stature.

These charts have been revised and are available from the Centers for Disease Control and Prevention (2000 CDC Growth Charts: United States).[26] The new charts are applicable to infants, children, and adolescents from birth to age 20 years and have 7 percentile curves (5th, 10th, 25th, 50th, 75th, 90th, 95th). Charts are available for use in subspecialty patients (eg, endocrine, gastroenterology), with additional third and 97th percentile curves. Body mass index (BMI) charts, which are available for individuals aged 2-20 years, have replaced the weight-for-stature charts. BMI is calculated by dividing weight in kilograms by height in meters squared.

Accurate measurements are essential to the interpretation of growth charts. Scales need to be regularly calibrated; length should be carefully measured, and head circumference should be measured using standardized techniques.

WHO has recommended the use of z-scores in expressing anthropometric measurements. Z-scores allow more precision in describing anthropometric status than does the customary placement “near” or “below” a certain percentile curve.[9]

Alternate growth charts are available for children who are breastfed and for children with multiple genetic conditions including Down syndrome,[27]  Turner syndrome,[28] achondroplasia,[29] meningomyelocele, low birth weight, and very low birth weight. No matter which growth chart is used, the most valuable information is obtained by careful measuring and plotting on the same chart over time. Infants and children should remain within 1-2 percentile curves over time.

Other anthropometric variables for assessing nutritional status

In acutely ill children, height and weight measurements may be challenging to accurately record due to difficulty in transporting critically ill children, or to fluid shifts that affect the measurement. Mid–upper arm circumference (MUAC) has been suggested as a proxy for weight and HC as a proxy for height. In patients with fluid shifts and edema, MUAC may be a better indicator than weight-for-height for classification of acute malnutrition. MAMC and triceps skinfold are other measurements that are useful in children where height and weight measurements are not easily acquirable. Mid-arm muscle circumference (MAMC) may be calculated from MUAC and triceps skin fold (TSF) using the formula MAMC = MUAC – (TSF × 0.314).[9]

Epidemiology

Frequency

United States

In reports from 1980-1989, failure to thrive accounted for 1-5% of tertiary hospital admissions for infants younger than 1 year. As many as 10% of children in primary care settings and 5% of US hospitalized children have been reported to show signs of failure to thrive.[30, 10]  The incidence is highest in children with prematurity and with other medical conditions. The proportion of nonorganic failure to thrive among all infants with failure to thrive is much higher in the United States and other industrialized countries than in the developing nation.

International

In underdeveloped countries, malnutrition manifesting as failure to thrive is more common. Worldwide, underweight prevalence was projected to decline from 26.5% in 1990 to 17.6% in 2015, a change of –34% (95% confidence interval [CI], –43% to –23%). In developed countries, the prevalence was estimated to decrease from 1.6% to 0.9%, a change of –41% (95% CI, –92% to 343%). In developing regions, the prevalence was forecasted to decline from 30.2% to 19.3%, a change of –36% (95% CI, –45% to –26%). In Africa, the prevalence of underweight was forecasted to increase from 24.0% to 26.8%, a change of 12% (95% CI, 8%-16%). In Asia, the prevalence was estimated to decrease from 35.1% to 18.5%, a change of –47% (95% CI, –58% to –34%). Worldwide, the number of underweight children was projected to decline from 163.8 million in 1990 to 113.4 million in 2015, a change of –31% (95% CI, –40% to –20%). Numbers are projected to decrease in all subregions except the subregions of sub-Saharan, Eastern, Middle, and Western Africa, which are expected to experience substantial increases in the number of underweight children. Thus, neither the world as a whole, nor the developing regions, achieved the Millennium Development Goals of decreasing the prevalence by 50% from 1990 to 2015. This is largely due to the deteriorating situation in Africa where all subregions, except Northern Africa, are expected to fail to meet the goal.[31]

Mortality/Morbidity

The global trend in chronic failure to thrive (referred to as stunting) prevalence and numbers affected is decreasing. Between 2000 and 2013 stunting prevalence declined from 33% to 25% and numbers declined from 199 million to 161 million. In 2013, about half of all stunted children lived in Asia and over one third in Africa. Globally, 51 million children under-five years of age were acutely malnourished (wasted) and 17 million were severely wasted. Globally, wasting prevalence in 2013 was estimated at almost 8% and nearly a third of that was for severe wasting, totaling 3%. Approximately two thirds of all wasted children lived in Asia and almost one third in Africa, with similar proportions for severely wasted children.[32]

Ultimate physical growth and cognitive development may be decreased in children with long standing failure to thrive, especially with an early onset. However, efforts to analyze the published data have not yielded unequivocal confirmation in children in the developing world.[33] Earlier publications have described more cognitive deficits in nonorganic than organic failure to thrive.[34]

In developing countries, malnutrition is a significant cause of mortality, whether directly or secondary to complications (eg, infection). Among children with certain illnesses, failure to thrive is an independent risk factor for premature mortality, such as with HIV infection [35] and epidermolysis bullosa.[36]

Race

Failure to thrive can occur in all socioeconomic strata, although it is more frequent in families living in poverty. Studies indicate increased incidence in children receiving Medicaid, children living in rural areas, and children who are homeless.

Sex

Nonorganic failure to thrive is reported more commonly in females than in males. In certain areas of the world where there is nutrient shortage, distribution is sometimes gender based yielding greater prevalence in females.

Age

The term is mainly reserved for growth compromise in young children.

Prognosis

Multiple studies have investigated whether failure to thrive is associated with long-term cognitive deficits.[33, 37, 38] Two published meta-analyses looking at cognitive outcomes of published children with failure to thrive in developed countries found small differences consisting of 3-4 IQ points.[33, 38] Interestingly, one group concluded that this disparity was not enough to warrant an aggressive approach to identification and treatment of this entity.[33] The other authors suggested substantial population-based cognitive deficiencies could be attributed to failure to thrive.[38]

Another longitudinal population study of a large cohort found the same degree of IQ score difference when they examined a cohort with infantile failure to thrive.[39] A separate study that further divided nonorganic failure to thrive into those who had or had not experienced neglect defined a particularly vulnerable cohort; failure to account for this additional variable may explain some differences.[40]

A new area of research has been exploring whether aggressive refeeding or early malnutrition itself could impact future health parameters independent of simply changes in BMI and growth. The Barker or Fetal Origins Hypothesis is based on data accumulated over the last 20 years that has linked low birth weight to a subsequent increased risk for cardiovascular disease and type 2 diabetes. This theory states that in utero nutrient restriction results in epigenetic modifications that reprogram intermediary metabolism, glucose regulation, and blood pressure regulation. These genetic changes persist into adult life and yield increased susceptibility to disease.

A few epidemiologic studies have hypothesized that this principle could be extended to include malnutrition occurring in early postnatal life. A comprehensive review summarizes the published literature in this field and concludes that children with early-onset enteric infections, malnutrition, and stunting appear to be at increased risk to ultimately develop the metabolic syndrome.[41] A small observational study describes a cohort of young children with severe failure to thrive who received aggressive nutritional rehabilitation and ultimately developed obesity.[42] Whether this was a consequence of the primary deficit or the therapy is not addressed.

Potential long-term psychosocial consequences of stunting secondary to growth failure in early childhood in the developing world have been highlighted by a longitudinal study following a rural Guatemalan cohort.[43] Affected individuals went on to have profound consequences in adulthood related to economic status, marriage, and fertility. They scored worse on tests of reading and intelligence and had lower cognitive skills. Men had decreased likelihood of entry into higher-salaried positions. Individuals who were stunted often entered into relationships with poorer partners and were more likely to live in poorer households as adults. Women with stunting had their first child at a younger age and had more pregnancies and more children. While provocative, the potential for other economic, educational, or sociologic factors being the primary explanation for these outcomes still needs to be considered.

Although the goal of all pediatricians caring for children with organic failure to thrive is to incorporate measures into their management that are designed to preserve adequate growth, this may prove to be difficult. A greater appreciation for the significant prevalence of failure to thrive in children with multiple chronic illnesses including cerebral palsy (CP), congenital heart disease, cystic fibrosis, cirrhosis, HIV, inflammatory bowel disease, malignancy, and genetic diseases has been noted as well as the contribution of FTT to the ultimate outcomes in these patients.

History

The most important part of the evaluation of a child with failure to thrive (FTT) is obtaining a careful, detailed history. Once identified, the history can reveal whether the failure to thrive is organic, nonorganic (no identifiable physical conditions contributing to the problem),[44, 45, 46] or has components of both. As suggested above, the keen clinician will strive to identify subtle organic problems that may influence eating in seemingly healthy but deprived children as well as psychosocial challenges that further compromise intake in sick children.[21, 16]

The next step is to establish whether the parent of a child with organic failure to thrive feels that it is related to decreased intake, increased losses (eg, diarrhea, emesis) or abnormal metabolism (chronic illnesses, especially cardiopulmonary illnesses that increase the basal metabolic rate). Often times, multiple factors can coalesce in a single patient.

The history should include the following:

Physical

The first thing that pediatricians should do in all health assessments is to plot the head circumference, height, and weight on a growth chart. Previous growth parameters should be used to detect trends in growth rather than relying on measurements at one particular visit. If weight, height, and head circumference are all compromised, this suggests an in utero insult and/or genetic or chromosomal abnormality (see the image below).



View Image

Failure of growth in weight, length, and head circumference starting at birth, suggesting an organic etiology that occurred in utero.

If weight and height growth are delayed with a normal head circumference, endocrinopathies (see the first 2 images below) or constitutional delay (see the third image below) should be suspected.



View Image

Growth failure in length and weight with a normal head circumference in an infant with growth hormone deficiency.



View Image

Acquired hypothyroidism.



View Image

Constitutional delay of growth.

This pattern also can occur in long-standing failure to thrive. Ultimately, head circumference is delayed, emphasizing the importance of following these growth parameters over time. When only weight gain is delayed, this usually reflects recent energy (caloric) deprivation (see the image below).



View Image

Failure to thrive secondary to caloric deprivation.

Vital signs are usually within the reference range, but blood pressure, respiration rate, pulse rate, and oxygen saturation may provide important clues regarding the etiology.

 

Causes

Failure to thrive can be organized into nonorganic failure to thrive, organic failure to thrive, and a combination of nonorganic and organic failure to thrive. The relative incidence of each category completely depends on the population that the study examines. A study from a pediatric endocrinology clinic in a US university hospital found that half of the patients had a purely nutritional deficiency and another quarter had short stature.[30] As indicated above, many of the children from older articles who were considered to have nonorganic failure to thrive actually had subtle organic problems that contributed to their poor growth.

While the authors believe that most children have contributions from both etiologies, guidelines are being composed to assist clinicians with unclear circumstances.  A retrospective review compiled by a national children's hospital in Korea concluded that in their population, children with organic failure to thrive had significantly lower gestational ages, birth weights, and weight percentiles at presentation than those with nonorganic failure to thrive. In addition, the children with organic failure to thrive were more likely to have severe weight decline.[48]

Nonorganic failure to thrive

Nonorganic failure to thrive, the most written about form of failure to thrive results from adverse environmental and psychosocial factors.[49] The onset is almost always prior to age 5 years. It is often associated with abnormal interactions between the caregiver and the infant or child. At times, it can be part of a more global pattern of child abuse. The result is an inadequate provision of food and/or inadequate intake of food. It is most common in the setting of poverty. When considering almost all of the individual entities associated with nonorganic failure to thrive, an organic process can frequently be identified as an accomplice. 

Prenatal causes of nonorganic failure to thrive include the following:

Postnatal causes of nonorganic failure to thrive include the following:

Nonorganic causes of failure to thrive usually include combinations of the following:

Organic failure to thrive

Prenatal onset of organic failure to thrive involves the following:

Although the differential diagnosis of postnatal organic failure to thrive is vast, dividing the etiology is useful. The etiology can be divided into the following 3 general areas: inadequate energy intake, compromised use (usually vomiting or malabsorption and/or excessive losses), and excessive metabolic demands. An astute mother recognizes the category to which her baby belongs. The astute physician recognizes patterns that encompass more than one of these categories.

Causes of inadequate energy intake include the following:

Inadequate use of ingested energy includes the following:

Illnesses that increase metabolic demands include the following:

An important part of the evaluation of all children is observation of the infant while feeding. This elucidates maternal-infant interactions, the infant's ability to suck and swallow, and the general health, development and fatigability of the child.

Genetic short stature and constitutional delay of growth are 2 conditions associated with decreased growth that must be distinguished from failure to thrive. From birth to about age 2 years, a baby's weight changes to follow the genetic predisposition of the parents' height and weight. During this time of transition, children with genetic short stature may cross percentiles downward and still be considered normal. However, most children in this category find their true growth curve by age 3 years. Although children with genetic short stature are often below the third percentile on the growth chart, they have normal weight-to-height ratios and bone ages equal to their chronological ages.

The other condition associated with short stature that must be distinguished from failure to thrive is constitutional growth delay, another variation of normal growth. Children with short stature resulting from constitutional delay often have a family history of delayed growth and puberty. They have a deceleration of growth in the first 2 years that can be confused with failure to thrive, but then grow parallel to but below the third percentile. Puberty is delayed, but ultimate height may be normal. A distinguishing point from genetic short stature is that bone age is delayed.

Table 1. Summary of Organic Causes of Failure to Thrive



View Table

See Table

Combined organic and nonorganic failure to thrive

Failure to thrive is now becoming more commonly recognized as the result of both organic and nonorganic reasons.[14, 15]  In a recent multicenter study nearly one-half of children hospitalized for FTT had a complex chronic condition. However, the authors also realized that children with prematurity-related conditions and low median household income represent unique populations at higher risk for FTT readmissions.[59]  Among the many infants with psychosocial deprivation, those with growth compromise often exhibit subtle evidence of dysphagia.

Conversely, some children with chronic illnesses who have failure to thrive may have additional psychosocial issues that compromise adequate treatment for their primary organic disease. These would include poverty, lack of education, concurrent family emergencies or natural disasters, and dysfunctional or ill caretakers, who may have psychological or behavioral co-morbidities themselves. Illnesses in children, particularly chronic illnesses, may create insurmountable psychological, emotional, and financial burdens for certain families. Stresses from coping with chronic illnesses may lead to parental dysfunction, such as depression, alcohol or drug abuse, divorce, or chaotic home environments. Parental dysfunction and the resultant negative atmosphere in which children are reared affect their food intake. Among the many infants with psychosocial deprivation, those with growth compromise often exhibit subtle evidence of dysphagia.

Children may also undergo personality changes when they have chronic diseases. Medications (eg, steroids) are well known to cause behavioral changes, but the mere presence of a chronic illness can also result in resistance or noncompliance in many aspects of a child's life, including consumption of proper energy intake. This is most common when the chronic illness includes the GI tract (eg, Crohn disease) or is especially debilitating (eg, HIV, difficult to treat neoplasia). As psychologists identify a greater proportion of children with chronic diseases who have depression as a comorbidity, this possible cause of failure to thrive should not be overlooked.

Special concerns and medicolegal issues

A recently published systematic review of failure to thrive in affluent societies reveals expected conclusions in this population.[60] Since psychosocial deprivation is very rarely encountered in this cohort, the incidence of failure to thrive is less than anticipated in an unselected group of children. In addition, most measurements that fall below the defined cutoff represent transient events leading to temporary weight loss rather than significant chronic problems. The authors correctly recommend that children from this demographic should only be evaluated for failure to thrive when they meet the criteria over an extended period, rather than simply making this diagnosis based on a single set of measurements.

Failure to identify a child with a potentially treatable cause of organic failure to thrive that leads to permanent sequelae secondary to a delay in diagnosis is a pitfall. Conversely, failure to refer a child who requires protective services while being evaluated for nonorganic failure to thrive who sustains an inflicted complication is yet another potential pitfall.

Perhaps the greatest challenge for healthcare providers evaluating children with failure to thrive is to identify if the family seeking medical input is thinking of the best interest of the child. Medical child abuse (MCA), a form of Munchausen syndrome by proxy, is defined as a caretaker seeking unnecessary and harmful or potentially harmful medical care and/or procedures. A recent article published in Pediatrics provides the most cogent guidelines to date, and physicians should familiarize themselves with the risk stratification tool developed by this group.[61]

The review was based on a retrospective chart review comparing 17 cases of MCA to 68 controls from the same location and the same years with failure to thrive but without MCA. Features that distinguished MCA patients were involvement of multiple subspecialists in children without congenital anomalies, parents seeking input from multiple institutions, parents refusing services from a multidisciplinary feeding team or not allowing social workers into their homes, siblings with similar complaints, and children with multiple allergies restricting their caloric intake and leading to multiple formula changes.

The MCA cohort were also subjected to significantly more invasive procedures (1) to make a diagnosis (including upper endoscopy and muscle biopsy) and (2) to provide supplemental calories (nasogastric tube feedings, gastrostomy tube placement, Nissen fundoplication, and placement of a central line for parenteral nutrition).

Their model was able to predict MCA with a sensitivity of 100% and a specificity of 96%. However, this application was based on a small number of MCA cases, not all of whom were definitively identified as having this problem. In addition, it was derived from a specialized referral unit and may not be universally applicable.

The authors do agree with the conclusions from this review that the presence of inconsistencies over time and the pattern of increasingly more invasive investigations to identify a cause of the failure to thrive, or the necessity of increasingly more invasive procedures to provide adequate calories is alarming. Despite the trend to minimize hospitalization in general, including as part of the failure to thrive algorithm, there are certain circumstances in which the child must be observed to determine the precise nature of the problem. These become more compelling when the experienced clinician is faced with clinical events that stray further and further from what would be expected.

Physical Examination

The physical examination may reveal the following abnormalities in children with organic basis for failure to thrive:

Decreased weight secondary to marasmus (caused by insufficient caloric intake) should be distinguished from decreased weight secondary to acute dehydration. Only the latter is characterized by decreased skin turgor, sunken anterior fontanelle, dry mucous membranes, absence of tears, and acutely ill appearance.

Laboratory Studies

Because many instances of failure to thrive are nonorganic, a history and physical examination are normally all that are required. Laboratory assessment has a limited value in diagnosing a previously unknown clinical disease or demonstrating inadequate treatment (ie, improper regiments or more commonly noncompliance).[62, 63]  

Children diagnosed with failure to thrive usually undergo certain screening tests that are more helpful in determining their physical status rather than elucidating the etiology. These often including the following:

More specific tests may be indicated, depending on findings from the history and physical examination, including the following:

If concern surrounds possible growth hormone deficiency, the following may be obtained:

Note that in patients with failure to thrive, the growth hormone axis may be secondarily affected, a condition referred to as deprivational dwarfism.

Imaging Studies

Bone age may be helpful in distinguishing genetic short stature from constitutional delay of growth. Chest radiography is helpful in assessing cardiopulmonary disease.

For a child with suspected dysphagia, which may present as coughing, choking, difficulty with certain consistencies of food, or food refusal, video cinefluoroscopy can be an extremely valuable study. Also called a modified barium swallow, the infant is given liquids and solids of varying consistency under the direction of a feeding therapist who collaborates with the radiologist to film the swallows. Subsequently, the film can be slowed down to evaluate the various phases of swallowing and document penetration and aspiration.

Procedures

Other diagnostic procedures may be appropriate and are performed as indicated.

A recent retrospective study on the indications for diagnostic upper endoscopy found that failure to thrive was among the top 3 conditions prompting this invasive investigation. The majority of children were found to have normal findings. The yield of identifying previously unrecognized problems that could have contributed to the failure to thrive was low and included gastritis (22%), esophagitis (14%), and celiac disease (2.6%).[64] Frequently, physical findings and or a history are characteristic for acid peptic disease (gastritis, esophagitis, duodenitis, peptic ulcer) and can be treated empirically. Celiac disease can be suggested by positive tissue transglutaminase IgA, but present guidelines recommend biopsy to confirm the diagnosis.. A recent article from a medical school based feeding program found that virtually the only successful applications of endoscopic procedures was for children with medical diagnoses that were responsible for the FTT.[63]

Approach Considerations

The primary determination is to recognize and adequately address the secondary contributors to growth impairment even after appropriate categorization into the three main etiologies: inadequate intake, increased metabolic demand, or inefficient utilization of adequate intake.

Approach each child as being on a spectrum in which pure organic and non organic failure are at the extremes and most have multiple reasons for their inadequate intake.  

 

Medical Care

Most children with failure to thrive (FTT) can be treated as outpatients. However, serial visits are mandatory, with documentation of weight gain and/or daily caloric intake. Home visits can help determine the underlying reason for the nonorganic failure to thrive and can help support the caregiver. If outpatient trials do not lead to documented weight gain, then hospitalization is necessary for diagnostic and therapeutic reasons. Diagnostic benefits of admission may include observation of feeding, parental-child interaction, and dietary habits. Additionally, specific tests can be performed and subspecialists can be consulted in this setting.

If no weight gain is documented after several days of allowing the caregiver to feed the child with close observation in a structured setting, then experienced hospital personnel must take over feeding. Failure to gain weight under these circumstances strongly suggests that an organic etiology is making a major contribution or that a complex behavioral issue is present. Conversely, if weight gain is documented by other caregivers, then improving the behavioral dynamics of the child and parent becomes the focus.

Therapeutic benefits should be anticipated from hospitalization. Acute needs, such as dehydration, infection, anemia, or electrolyte imbalance, can be addressed and managed with intravenous fluids, systemic antibiotic therapy, and transfusion. If no weight gain is documented by alternative caregivers, then a trial of nasogastric tube feeding should be implemented to see if the child can absorb enough energy if adequate amounts are provided to grow. If not, administration of simplified nutritional products or even parenteral nutrition can be initiated while a comprehensive understanding of the deficits are sought. Once the organic etiology is found, specific therapy should be immediately initiated during the hospitalization.

Another benefit of hospitalization is the opportunity for observing the parent-child interaction. In addition to the feeding techniques of the parents, other interactions can be observed more easily in the hospital. Multiple observers should assess and document the degrees to which parents bond, speak, and even interact with their children.

A provocative report analyzed hospitalization for failure to thrive and found that there was an increased length of stay (and cost) associated with weekend admission.[65] While the data presented represent their experience, it is important for practitioners to be aware of this phenomenon and create explicit data collection goals for the weekend inpatient team. This increases the likelihood that valuable information is collected. For situations that do require hospitalization of children of working parents, often with additional school-aged children, a 10-day admission that includes 2 weekends would minimize interruption of school and work and, therefore, be optimal.

 

Surgical Care

Children born with congenital anomalies of their GI tract require surgical corrective procedures to provide for a continuous patent system to digest and absorb nutrition. Unfortunately, the surgically corrected system is often problematic and can interfere with adequate growth. An experienced pediatric surgeon should be actively involved in the care of a child with failure to thrive who has previously had GI tract surgery.

There is also some data that suggest that complicated NICU stays can be associated with long standing feeding aversion related to the stressors of early life.[66]

Consultations

When treating children with failure to thrive, an interdisciplinary team approach combining pediatric, nutritional, mental health, and social work is optimal. An interdisciplinary approach ensures that programs such as women, infants, and children (WIC); food stamps; and Medicaid can be accessed. The team should also coordinate home-based services and follow up after discharge.

An interdisciplinary team should evaluate the family's psychosocial situation and determine if future support is required. An older child with a chronic illness and failure to thrive may benefit from referral to a psychologist. If neglect is suspected, child protective services should become involved. Pediatric medical or surgical subspecialists should be involved in the long-term treatment and monitoring of organic illness if identified.

Clinical Interventions for FTT

Feeding Therapy

The child with failure to thrive who presents with what appears to be either a defined illness or as a non organic FTT, often has feeding and swallowing deficits.  Speech-language pathologists have been involved in the assessment of and management of pediatric feeding and swallowing disorders since the 1930’s.  These individuals are commonly speech therapists who have received additional training in the physiology of the oropharyngeal phase of swallowing. Their roles in treating feeding and swallowing disorders include the following.

Diagnostic

Behavioral Interventions

Like all other forms of physical and or occupational therapy, a prolonged regimen of training the family and implementing the program is often required to correct deficits.

The scope includes educating and training the parent/care provider to implement improved feeding and swallowing programs .This includes the foods to work on, ways to enhance calories, feeding schedules, textures, amounts and modifying approaches as progress is made.

Children with FTT may demonstrate a variety of behaviors to avoid eating including crying, tantrums, throwing food, excessive talking, vomiting and expelling food. Parents respond to these behaviors by coaxing, pleading, yelling, and threatening which provide attention to the child’s refusal behavior.

In a review of 38 treatment intervention studies of subjects with medical conditions, the primary focus was to describe the behavioral components of the intervention. In 21 of the 38 intervention studies ignoring was paired with providing attention contingent on appropriate mealtime behaviors like eating. Positive reinforcement was the most common component described. Positive reinforcement helped teach the children that eating was no longer associated with discomfort and instead became an enjoyable activity.[69]

A variety of behavioral therapy methods have been successfully employed to treat feeding refusal.[70, 71, 72, 73, 74]

A significant addition to treat the difficult FTT child has been the development of comprehensive behavioral treatment programs. These can be at inpatient, or outpatient centers or through  home based therapy programs. The goal includes teaching parents and caregivers how to continue the intervention and ultimately change the child’s behavior. The parents are often directed to provide a good proportion of this therapy with additional home visits by the therapist.

The time it takes to successfully implement behavioral treatment programs varies with the severity of the child’s condition and the intensity of the treatment program. Some children can be treated on an outpatient basis in their home by a specially trained speech pathologist with daily follow through by the parent or caregivers. Other children require more intensive treatment interventions that are possible only with daily outpatient or inpatient intervention for many weeks.  For extreme cases, hospital-based outpatient and inpatient feeding programs have been successful

A study looking at weight recovery of children in an interdisciplinary specialty practice found that the greatest weight recovery over a 6 month period in younger children and in children who had multiple risk child related and/ or household risk factors.[75] The greater recovery in younger children emphasizes the importance of implementing these interventions early before habit formations.

Rarely, the practitioner encounters a child with nonorganic failure to thrive secondary to a disordered family unit that appears resistant to remedial therapy. A recent comprehensive review provides an invaluable resource for caregivers, “Hope for children and families”.[76] The manual represents an analysis of 22 randomized controlled trials on situations in which children are subjected to harmful or neglectful parenting. The recommendations include providing individual therapy for the parent, promoting family engagement, positive reinforcement for the parent, and teaching both coping and nutritional skills.

Diet

The long-term goal for every child with failure to thrive is to provide adequate energy intake for growth.[77] For a child with organic failure to thrive, aggressive dietary management is the cornerstone of therapy. Additional caloric intake can be achieved with formulas that provide 120 kcal/kg of ideal body weight per day for infants who cannot ingest the required volume of standard formula. Usually, the density is increased from 20 to 24-27 kcal/oz. Some clinicians prefer to achieve the same result by adding lipids, carbohydrates, combinations of both, and (rarely) protein to standard 20 kcal/oz formulas.

Infants given concentrated formulas must have normal renal function because the osmolar load is proportionally higher as well. Infants and children with cardiopulmonary disease may require additional energy to compensate for the additional work of breathing so rapidly. They will benefit from lipid supplementation because fat is burned with a lower respiratory coefficient, yielding less CO 2 to expire than carbohydrate or protein.

Supplementation for older children may include adding meat sauces, oil, cheese, sour cream, butter, margarine, or peanut butter to meals. Also, high-energy (approximately 1 kcal/mL) shakes, which are available in different flavors, provide a good supplement (eg, Pedia Sure, Kindercal, Boost). Multivitamin and mineral supplements, including iron and zinc, are usually recommended to all undernourished children.

Temporary tube feeding is rarely indicated, except for in children with severe malnutrition and debilitation. In infants or children with organic failure to thrive that is secondary to high energy demands or significant dysphagia, long-term continuous nighttime tube feeding may be required to sustain growth.

Table 2. Examples of High-Calorie Fortifiers



View Table

See Table

Table 3. Examples of High-Calorie Nutritional Products



View Table

See Table

 

Many generic products offer a substantially less expensive, nutritionally adequate alternative.

Cyproheptadine

Clinical Context:  This medication has been utilized to stimulate appetite. It is given several times a day prior to meals and can cause lethargy. 

Further Outpatient Care

Children with failure to thrive (FTT) need continued follow-up care to observe their growth parameters using the appropriate growth charts.

A randomized controlled trial of multidisciplinary home visits among children with failure to thrive found mild improvement in some parameters compared with children with failure to thrive who only attended the same clinic. However, children without failure to thrive from the same neighborhoods were significantly taller, heavier, and had better arithmetic scores at age 8 years than children with failure to thrive with or without home visits.[78] An older randomized controlled trial of specialist health visitor interventions failed to show any improvements in weight or developmental scores but did find that visited patients were more compliant with appointments and less likely to be admitted to a hospital.[79]

Complications

Aside from the unfortunate children who live so far from the protective mechanisms of the developed world, psychosocial failure to thrive is almost always recognized early enough to be completely reversed. In the developing world, or regions of the developed countries with extreme poverty and isolation, chronic unaddressed malnutrition results in permanent deficits in stature and intelligence quotient (IQ), even when weight losses can be restored. Similarly, for the child with devastating or inadequately treated organic illnesses, long-term failure to thrive can compromise final height. Malnutrition, if dramatic enough, can contribute to secondary immune deficiency and intercurrent illnesses.

Prognosis

Multiple studies have investigated whether failure to thrive is associated with long-term cognitive deficits.[33, 37, 38] Two published meta-analyses looking at cognitive outcomes of published children with failure to thrive in developed countries found small differences consisting of 3-4 IQ points.[33, 38] Interestingly, one group concluded that this disparity was not enough to warrant an aggressive approach to identification and treatment of this entity.[33] The other authors suggested substantial population-based cognitive deficiencies could be attributed to failure to thrive.[38]

Another longitudinal population study of a large cohort found the same degree of IQ score difference when they examined a cohort with infantile failure to thrive.[39] A separate study that further divided nonorganic failure to thrive into those who had or had not experienced neglect defined a particularly vulnerable cohort; failure to account for this additional variable may explain some differences.[40]

A new area of research has been exploring whether aggressive refeeding or early malnutrition itself could impact future health parameters independent of simply changes in BMI and growth. The Barker or Fetal Origins Hypothesis is based on data accumulated over the last 20 years that has linked low birth weight to a subsequent increased risk for cardiovascular disease and type 2 diabetes. This theory states that in utero nutrient restriction results in epigenetic modifications that reprogram intermediary metabolism, glucose regulation, and blood pressure regulation. These genetic changes persist into adult life and yield increased susceptibility to disease.

A few epidemiologic studies have hypothesized that this principle could be extended to include malnutrition occurring in early postnatal life. A comprehensive review summarizes the published literature in this field and concludes that children with early-onset enteric infections, malnutrition, and stunting appear to be at increased risk to ultimately develop the metabolic syndrome.[41] A small observational study describes a cohort of young children with severe failure to thrive who received aggressive nutritional rehabilitation and ultimately developed obesity.[42] Whether this was a consequence of the primary deficit or the therapy is not addressed.

Potential long-term psychosocial consequences of stunting secondary to growth failure in early childhood have been highlighted by a longitudinal study following a rural Guatemalan cohort.[43] Affected individuals went on to have profound consequences in adulthood related to economic status, marriage, and fertility. They scored worse on tests of reading and intelligence and had lower cognitive skills. Men had decreased likelihood of entry into higher-salaried positions. Individuals who were stunted often entered into relationships with poorer partners and were more likely to live in poorer households as adults. Women with stunting had their first child at a younger age and had more pregnancies and more children. While provocative, the potential for other economic, educational, or sociologic factors being the primary explanation for these outcomes still needs to be considered.

Although the goal of all pediatricians caring for children with organic failure to thrive is to incorporate measures into their management that are designed to preserve adequate growth, this may prove to be difficult. A greater appreciation for the significant prevalence of failure to thrive in children with  most chronic illnesses including cerebral palsy (CP), congenital heart disease, cystic fibrosis, cirrhosis, HIV, inflammatory bowel disease, malignancy, and genetic diseases has been noted.

Patient Education

For patient education resources, see the Growth Hormone Deficiency Center, as well as Growth Failure in Children,

Author

Simon S Rabinowitz, MD, PhD, FAAP, Professor of Clinical Pediatrics, Vice Chairman, Clinical Practice Development, Pediatric Gastroenterology, Hepatology, and Nutrition, State University of New York Downstate College of Medicine, The Children's Hospital at Downstate

Disclosure: Nothing to disclose.

Coauthor(s)

Genie Rogers, MA, CCC-SLP, BRS-S, Speech-Language Pathologist, Infant and Child Learning Center, Neonatal Intensive Care Unit, Downstate University Hospital; Clinical Supervisor, Speech Therapy Services, Step by Step Infant Development Program

Disclosure: Nothing to disclose.

Navneetha Unnikrishnan, MBBS, Resident Physician, Department of Pediatrics, State University of New York Downstate College of Medicine

Disclosure: Nothing to disclose.

Specialty Editors

Mary L Windle, PharmD, Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Jatinder Bhatia, MBBS, FAAP, Professor of Pediatrics, Medical College of Georgia, Georgia Regents University; Chief, Division of Neonatology, Director, Fellowship Program in Neonatal-Perinatal Medicine, Director, Transport/ECMO/Nutrition, Vice Chair, Clinical Research, Department of Pediatrics, Children's Hospital of Georgia

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Nestle<br/>Serve(d) as a speaker or a member of a speakers bureau for: Nestle<br/>Received income in an amount equal to or greater than $250 from: Nestle.

Chief Editor

Jatinder Bhatia, MBBS, FAAP, Professor of Pediatrics, Medical College of Georgia, Georgia Regents University; Chief, Division of Neonatology, Director, Fellowship Program in Neonatal-Perinatal Medicine, Director, Transport/ECMO/Nutrition, Vice Chair, Clinical Research, Department of Pediatrics, Children's Hospital of Georgia

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Nestle<br/>Serve(d) as a speaker or a member of a speakers bureau for: Nestle<br/>Received income in an amount equal to or greater than $250 from: Nestle.

Additional Contributors

Maria Rebello Mascarenhas, MBBS, Professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania; Section Chief of Nutrition, Division of Gastroenterology and Nutrition, Director, Nutrition Support Service, Medical Director, Integrative Health Program, Children's Hospital of Philadelphia

Disclosure: Received research grant from: Kabi Fesinius<br/>Faculty member, DIGEST and member DSMB for: Cystic Fibrosis Foundation.

Acknowledgements

Rita Alvarez, MD Resident Physician, Department of Pediatrics, State University of New York Downstate Medical Center, Brooklyn

Rita Alvarez, MD is a member of the following medical societies: American Medical Student Association/Foundation

Disclosure: Nothing to disclose.

Reda W Bassali, MBChB Associate Professor, Departments of General Pediatrics and Adolescent Medicine, Medical College of Georgia

Reda W Bassali is a member of the following medical societies: Ambulatory Pediatric Association and American Academy of Pediatrics

Disclosure: Nothing to disclose.

John Benjamin, MD Chief, General Section of Pediatrics and Adolescent Medicine, Vice Chair for Clinical Activities, Professor, Department of General Pediatrics, Medical College of Georgia

Disclosure: Nothing to disclose.

Mohammad F El-Baba, MD Associate Professor of Pediatrics, Division of Pediatric Gastroenterology, Wayne State University School of Medicine; Divison Chief of Pediatric Gastroenterology, Children's Hospital of Michigan

Mohammad F El-Baba, MD is a member of the following medical societies: American Gastroenterological Assocation and North American Society for Pediatric Gastroenterology and Nutrition

Disclosure: Nothing to disclose.

Madhavi Katturupalli, MD Resident Physician, Department of Pediatrics, New York Medical College, Richmond University Medical Center

Madhavi Katturupalli, MD is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Ruby Mehta, MD Fellow, Division of Pediatric Gastroenterology, Children's Hospital of Michigan

Disclosure: Nothing to disclose.

References

  1. Bauchner H. Failure to Thrive. Nelson Textbook of Pediatrics. 18th Ed. Philadelphia, PA: WB Saunders; 2007. 37;184-7.
  2. Frank DA, Zeisel SH. Failure to thrive. Pediatr Clin North Am. 1988 Dec. 35(6):1187-206. [View Abstract]
  3. Porter B, Skuse D. When does slow weight gain become 'failure to thrive'?. Arch Dis Child. 1991 Jul. 66(7):905-6. [View Abstract]
  4. Zenel JA Jr. Failure to thrive: a general pediatrician's perspective. Pediatr Rev. 1997 Nov. 18(11):371-8. [View Abstract]
  5. Hoare KJ. A baby presenting with failure to thrive in primary care: a case report. Cases J. 2009. 2(1):137. [View Abstract]
  6. Leung DH, Chung CT. Cases in pediatric gastroenterology from The Children's Hospital of Philadelphia: a 2-year-old boy with diarrhea, failure to thrive, and hepatomegaly. Medscape J Med. 2009. 11(1):13. [View Abstract]
  7. Growth retardation indicators in children under 5 years old. Epidemiol Bull. 1998 Mar. 19 (1):13-6. [View Abstract]
  8. Olsen EM, Petersen J, Skovgaard AM, et al. Failure to thrive: the prevalence and concurrence of anthropometric criteria in a general infant population. Arch Dis Child. 2007 Feb. 92(2):109-14. [View Abstract]
  9. Mehta NM, Corkins MR, Lyman B, Malone A, Goday PS, Carney LN, et al. Defining pediatric malnutrition: a paradigm shift toward etiology-related definitions. JPEN J Parenter Enteral Nutr. 2013 Jul. 37 (4):460-81. [View Abstract]
  10. Schwartz ID. Failure to thrive: an old nemesis in the new millennium. Pediatr Rev. 2000 Aug. 21 (8):257-64; quiz 264. [View Abstract]
  11. Atalay A, McCord M. Characteristics of failure to thrive in a referral population: implications for treatment. Clin Pediatr (Phila). 2012 Mar. 51 (3):219-25. [View Abstract]
  12. Larson-Nath CM, Goday PS. Failure to Thrive: A Prospective Study in a Pediatric Gastroenterology Clinic. J Pediatr Gastroenterol Nutr. 2016 Jun. 62 (6):907-13. [View Abstract]
  13. Reilly SM, Skuse DH, Wolke D, Stevenson J. Oral-motor dysfunction in children who fail to thrive: organic or non-organic?. Dev Med Child Neurol. 1999 Feb. 41(2):115-22. [View Abstract]
  14. Olsen EM, Skovgaard AM. [Psychosomatic failure-to-thrive in infants and toddlers]. Ugeskr Laeger. 2002 Nov 25. 164(48):5631-5. [View Abstract]
  15. Skuse DH. Non-organic failure to thrive: a reappraisal. Arch Dis Child. 1985 Feb. 60(2):173-8. [View Abstract]
  16. Manikam R, Perman JA. Pediatric feeding disorders. J Clin Gastroenterol. 2000 Jan. 30(1):34-46. [View Abstract]
  17. Black MM, Tilton N, Bento S, Cureton P, Feigelman S. Recovery in Young Children with Weight Faltering: Child and Household Risk Factors. J Pediatr. 2016 Mar. 170:301-6. [View Abstract]
  18. Manikam R, Perman JA. Pediatric feeding disorders. J Clin Gastroenterol. 2000 Jan. 30 (1):34-46. [View Abstract]
  19. Field D, Garland M, Williams K. Correlates of specific childhood feeding problems. J Paediatr Child Health. 2003 May-Jun. 39 (4):299-304. [View Abstract]
  20. Williams KE, Field DG, Seiverling L. Food refusal in children: a review of the literature. Res Dev Disabil. 2010 May-Jun. 31 (3):625-33. [View Abstract]
  21. Yi SH, Joung YS, Choe YH, Kim EH, Kwon JY. Sensory Processing Difficulties in Toddlers With Nonorganic Failure-to-Thrive and Feeding Problems. J Pediatr Gastroenterol Nutr. 2015 Jun. 60 (6):819-24. [View Abstract]
  22. Jung JS, Chang HJ, Kwon JY. Overall Profile of a Pediatric Multidisciplinary Feeding Clinic. Ann Rehabil Med. 2016 Aug. 40 (4):692-701. [View Abstract]
  23. Wu YP, Franciosi JP, Rothenberg ME, Hommel KA. Behavioral feeding problems and parenting stress in eosinophilic gastrointestinal disorders in children. Pediatr Allergy Immunol. 2012 Dec. 23 (8):730-5. [View Abstract]
  24. Dellon ES, Gonsalves N, Hirano I, Furuta GT, Liacouras CA, Katzka DA, et al. ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013 May. 108 (5):679-92; quiz 693. [View Abstract]
  25. Rommel N, De Meyer AM, Feenstra L, Veereman-Wauters G. The complexity of feeding problems in 700 infants and young children presenting to a tertiary care institution. J Pediatr Gastroenterol Nutr. 2003 Jul. 37 (1):75-84. [View Abstract]
  26. [Guideline] Centers for Disease Control and Prevention. CDC Growth Charts. August 4, 2009.
  27. [Guideline] Cronk C, Crocker AC, Pueschel SM, et al. Growth charts for children with Down syndrome: 1 month to 18 years of age. Pediatrics. 1988 Jan. 81(1):102-10. [View Abstract]
  28. [Guideline] Lyon AJ, Preece MA, Grant DB. Growth curve for girls with Turner syndrome. Arch Dis Child. 1985 Oct. 60(10):932-5. [View Abstract]
  29. [Guideline] Horton WA, Rotter JI, Rimoin DL, Scott CI, Hall JG. Standard growth curves for achondroplasia. J Pediatr. 1978 Sep. 93(3):435-8. [View Abstract]
  30. Daniel M, Kleis L, Cemeroglu AP. Etiology of failure to thrive in infants and toddlers referred to a pediatric endocrinology outpatient clinic. Clin Pediatr (Phila). 2008 Oct. 47(8):762-5. [View Abstract]
  31. de Onis M, Blössner M, Borghi E, Frongillo EA, Morris R. Estimates of global prevalence of childhood underweight in 1990 and 2015. JAMA. 2004 Jun 2. 291 (21):2600-6. [View Abstract]
  32. Levels & Trends in Child Malnutrition: UNICEF-WHO-The World Bank Joint Child Malnutrition Estimates. WHO. Available at http://www.who.int/nutgrowthdb/summary_jme_2013.pdf?ua=1. 2014; Accessed: December 1, 2016.
  33. Rudolf MC, Logan S. What is the long term outcome for children who fail to thrive? A systematic review. Arch Dis Child. 2005 Sep. 90(9):925-31. [View Abstract]
  34. Drewett RF, Corbett SS, Wright CM. Cognitive and educational attainments at school age of children who failed to thrive in infancy: a population-based study. J Child Psychol Psychiatry. 1999 May. 40(4):551-61. [View Abstract]
  35. Prazuck T, Tall F, Nacro B, et al. HIV infection and severe malnutrition: a clinical and epidemiological study in Burkina Faso. AIDS. 1993 Jan. 7(1):103-8. [View Abstract]
  36. Lechner-Gruskay D, Honig PJ, Pereira G, McKinney S. Nutritional and metabolic profile of children with epidermolysis bullosa. Pediatr Dermatol. 1988 Feb. 5(1):22-7. [View Abstract]
  37. Reif S, Beler B, Villa Y, Spirer Z. Long-term follow-up and outcome of infants with non-organic failure to thrive. Isr J Med Sci. 1995 Aug. 31(8):483-9. [View Abstract]
  38. Corbett SS, Drewett RF. To what extent is failure to thrive in infancy associated with poorer cognitive development? A review and meta-analysis. J Child Psychol Psychiatry. 2004 Mar. 45(3):641-54. [View Abstract]
  39. Emond AM, Blair PS, Emmett PM, Drewett RF. Weight faltering in infancy and IQ levels at 8 years in the Avon Longitudinal Study of Parents and Children. Pediatrics. 2007 Oct. 120(4):e1051-8. [View Abstract]
  40. Mackner LM, Starr RH Jr, Black MM. The cumulative effect of neglect and failure to thrive on cognitive functioning. Child Abuse Negl. 1997 Jul. 21(7):691-700. [View Abstract]
  41. DeBoer MD, Lima AA, Oría RB, Scharf RJ, Moore SR, Luna MA, et al. Early childhood growth failure and the developmental origins of adult disease: do enteric infections and malnutrition increase risk for the metabolic syndrome?. Nutr Rev. 2012 Nov. 70(11):642-53. [View Abstract]
  42. Kim GJ, Furman LM. Obesity Outcomes in Children With a History of Failure to Thrive. Clin Pediatr (Phila). 2013 May 15. [View Abstract]
  43. Hoddinott J, Behrman JR, Maluccio JA, et al. Adult consequences of growth failure in early childhood. Am J Clin Nutr. 2013 Nov. 98(5):1170-8. [View Abstract]
  44. Berwick DM, Levy JC, Kleinerman R. Failure to thrive: diagnostic yield of hospitalisation. Arch Dis Child. 1982 May. 57(5):347-51. [View Abstract]
  45. Genero A, Moretti C, Fait P, Guariso G. [Non-organic failure to thrive: retrospective study in hospitalized children]. Pediatr Med Chir. 1996 Sep-Oct. 18(5):501-6. [View Abstract]
  46. Homer C, Ludwig S. Categorization of etiology of failure to thrive. Am J Dis Child. 1981 Sep. 135(9):848-51. [View Abstract]
  47. Crossin R, Cairney S, Lawrence AJ, Duncan JR. Adolescent inhalant abuse leads to other drug use and impaired growth; implications for diagnosis. Aust N Z J Public Health. 2016 Oct 23. [View Abstract]
  48. Yoo SD, Hwang EH, Lee YJ, Park JH. Clinical Characteristics of Failure to Thrive in Infant and Toddler: Organic vs. Nonorganic. Pediatr Gastroenterol Hepatol Nutr. 2013 Dec. 16(4):261-8. [View Abstract]
  49. Oates RK. Similarities and differences between nonorganic failure to thrive and deprivation dwarfism. Child Abuse Negl. 1984. 8(4):439-45. [View Abstract]
  50. Skuse DH. Non-organic failure to thrive: a reappraisal. Arch Dis Child. 1985 Feb. 60(2):173-8. [View Abstract]
  51. Shams N, Mostafavi F, Hassanzadeh A. Determinants of complementary feeding practices among mothers of 6-24 months failure to thrive children based on behavioral analysis phase of PRECEDE model, Tehran. J Educ Health Promot. 2016 Jun 23. 5:24. [View Abstract]
  52. Wu YP, Franciosi JP, Rothenberg ME, Hommel KA. Behavioral feeding problems and parenting stress in eosinophilic gastrointestinal disorders in children. Pediatr Allergy Immunol. 2012 Dec. 23 (8):730-5. [View Abstract]
  53. Vohr BR, Stephens BE, McDonald SA, et al. Cerebral palsy and growth failure at 6 to 7 years. Pediatrics. 2013 Oct. 132(4):e905-14. [View Abstract]
  54. Schwarz SM, Corredor J, Fisher-Medina J, Cohen J, Rabinowitz S. Diagnosis and treatment of feeding disorders in children with developmental disabilities. Pediatrics. 2001 Sep. 108(3):671-6. [View Abstract]
  55. Tannenbaum GS, Ramsay M, Martel C, Samia M, Zygmuntowicz C, Porporino M. Elevated circulating acylated and total ghrelin concentrations along with reduced appetite scores in infants with failure to thrive. Pediatr Res. 2009 May. 65(5):569-73. [View Abstract]
  56. Wali P, King J, He Z, Tonb D, Horvath K. Ghrelin and obestatin levels in children with failure to thrive and obesity. J Pediatr Gastroenterol Nutr. 2014 Mar. 58(3):376-81. [View Abstract]
  57. Velasco P, Clemente M, Lorite R, et al. The role of leptin in diencephalic syndrome. Pediatrics. 2014 Jan. 133(1):e263-6. [View Abstract]
  58. Järvinen KM, Nowak-Wegrzyn A. Food protein-induced enterocolitis syndrome (FPIES): current management strategies and review of the literature. J Allergy Clin Immunol Pract. 2013 Jul-Aug. 1(4):317-22. [View Abstract]
  59. Puls HT, Hall M, Bettenhausen J, Johnson MB, Peacock C, Raphael JL, et al. Failure to Thrive Hospitalizations and Risk Factors for Readmission to Children's Hospitals. Hosp Pediatr. 2016 Aug. 6 (8):468-75. [View Abstract]
  60. Wright CM, Garcia AL. Child undernutrition in affluent societies: what are we talking about?. Proc Nutr Soc. 2012 Nov. 71(4):545-55. [View Abstract]
  61. Mash C, Frazier T, Nowacki A, Worley S, Goldfarb J. Development of a risk-stratification tool for medical child abuse in failure to thrive. Pediatrics. 2011 Dec. 128(6):e1467-73. [View Abstract]
  62. Sills RH. Failure to thrive. The role of clinical and laboratory evaluation. Am J Dis Child. 1978 Oct. 132(10):967-9. [View Abstract]
  63. Larson-Nath CM, Goday PS. Failure to Thrive: A Prospective Study in a Pediatric Gastroenterology Clinic. J Pediatr Gastroenterol Nutr. 2016 Jun. 62 (6):907-13. [View Abstract]
  64. Sheiko MA, Feinstein JA, Capocelli KE, Kramer RE. Diagnostic yield of EGD in children: a retrospective single-center study of 1000 cases. Gastrointest Endosc. 2013 Jul. 78(1):47-54.e1. [View Abstract]
  65. Thompson RT, Bennett WE Jr, Finnell SM, Downs SM, Carroll AE. Increased length of stay and costs associated with weekend admissions for failure to thrive. Pediatrics. 2013 Mar. 131(3):e805-10. [View Abstract]
  66. Hyman P. Role of Development in Infant and Toddler Food Refusal. SIG 13 Perspectives on Swallowing and Swallowing Disorders (Dysphagia). October 2010. 19:64-67.
  67. Arvedson J, Brodsky L. Pediatric Swallowing and Feeding , Assessment and Management. Second Edition. Singular Publishing Co.; 2002.
  68. American Speech-Language-Hearing Association. Roles of speech-language pathologists in swallowing and feeding disorders: Position statement. 2002. ASHA Supplement 22:73.
  69. Williams KE, Field DG, Seiverling L. Food refusal in children: a review of the literature. Res Dev Disabil. 2010 May-Jun. 31 (3):625-33. [View Abstract]
  70. Piazza CC, Carroll-Hernandez TA. Assessment and Treatment of Pediatric Feeding Disorders. Encyclopedia on Early Childhood Development. March 11, 2004. 1-7.
  71. Addison LR, Piazza CC, Patel MR, Bachmeyer MH, Rivas KM, Milnes SM, et al. A comparison of sensory integrative and behavioral therapies as treatment for pediatric feeding disorders. J Appl Behav Anal. 2012 Fall. 45 (3):455-71. [View Abstract]
  72. Seiverling L, Kokitus A, Williams K. A clinical demonstration of a treatment package for food selectivity. The Behavior Analyst Today. 2012. 13(2):11-16.
  73. Seiverling L, Harclerode W, Williams KE. The Effects of a Modified Treatment Package With and Without Feeder Modeling on One Child's Acceptance of Novel Foods. Education and Treatment of Children. August 2014. 37(3):477-493.
  74. Williams KE, Seiverling LJ. The assessment and treatment of feeding problems among children with autism spectrum disorders. Patel VB, Preedy VR, Marin CR. Comprehensive Guide to Autism. Springer; 1973-1993.
  75. Black MM, Tilton N, Bento S, Cureton P, Feigelman S. Recovery in Young Children with Weight Faltering: Child and Household Risk Factors. J Pediatr. 2016 Mar. 170:301-6. [View Abstract]
  76. Bentovim A, Elliott I. Hope for children and families: targeting abusive parenting and the associated impairment of children. J Clin Child Adolesc Psychol. 2014. 43(2):270-85. [View Abstract]
  77. Maggioni A, Lifshitz F. Nutritional management of failure to thrive. Pediatr Clin North Am. 1995 Aug. 42(4):791-810. [View Abstract]
  78. Black MM, Dubowitz H, Krishnakumar A, Starr RH Jr. Early intervention and recovery among children with failure to thrive: follow-up at age 8. Pediatrics. 2007 Jul. 120(1):59-69. [View Abstract]
  79. Black MM, Dubowitz H, Hutcheson J, Berenson-Howard J, Starr RH Jr. A randomized clinical trial of home intervention for children with failure to thrive. Pediatrics. 1995 Jun. 95(6):807-14. [View Abstract]

Failure of growth in weight, length, and head circumference starting at birth, suggesting an organic etiology that occurred in utero.

Growth failure in length and weight with a normal head circumference in an infant with growth hormone deficiency.

Acquired hypothyroidism.

Constitutional delay of growth.

Failure to thrive secondary to caloric deprivation.

Failure of growth in weight, length, and head circumference starting at birth, suggesting an organic etiology that occurred in utero.

Growth failure in length and weight with a normal head circumference in an infant with growth hormone deficiency.

Acquired hypothyroidism.

Constitutional delay of growth.

Failure to thrive secondary to caloric deprivation.

Prenatal causes
  • Prematurity with complications
  • Maternal malnutrition
  • Toxic exposure in utero
  • Alcohol, smoking, medications, infections
  • IUGR
  • Chromosomal abnormalities
Postnatal causesInadequate intake



  • Lack of appetite (chronic illness)
  • Inability to suck or swallow
  • Vomiting
  • Therapy used to treat primary illness (eg, chemotherapy)
  • Developmental delay
  • GI pain or dysmotility
Poor absorption and/or use of nutrients



  • Malabsorption
  • Anatomical GI problems
  • Pancreatic and cholestatic conditions
  • Inborn errors of metabolism
  • Chronic GI infections
Increased metabolic demand



  • HIV infection
  • Malignancy
  • Cardiopulmonary diseases and inflammatory conditions
  • Renal failure
  • Hyperthyroidism
Product Calories Source
Medium-chain triglyceride (MCT) oil7.7 kcal/mLFractionated coconut oil
Microlipid4.5 kcal/mLSafflower oil
Corn oil8.4 kcal/mLCorn
ProMod (protein powder)28 kcal/scoop (4.2 kcal/g)



5 g/scoop



Whey protein with lecithin
Polycose (powder or liquid)Powder - 23 kcal/tbsp



Liquid - 30 kcal/tbsp



Powder - Hydrolyzed cornstarch



Liquid - Glucose polymers derived from hydrolyzed cornstarch



Rice cereal (powder)15 kcal/tbspRice flour
Nonfat dry milk powder15 kcal/T (1.5 g protein)Cow's milk
Powder infant formula40 kcal/tbspCow's milk
Liquid concentrated infant formula40 kcal/ozCow's milk
Product, 30 kcal/oz CHO, g/100 mL Protein, g/100 mL Fat, g/100 mL Osmolality Nutrient Sources
Nutren Junior



(Clintec)



12.834.2350CHO - Maltodextrin, sucrose



Protein - Casein, whey



Fat - Soy, MCT, and canola oils



(Vanilla, also available with fiber)



Kindercal



(Mead Johnson)



13.53.44.4310CHO - Maltodextrin, sucrose



Protein - Caseinates, milk protein concentrate



Fat - Canola, MCT, and high-oleic sunflower oils



Contains soy fiber 6.3 g/L



(Vanilla)



PediaSure



(Ross)



1135310CHO - Corn syrup solids, sucrose



Protein - Caseinate, whey protein concentrate



Fat - High-oleic safflower, soy, and MCT oils



(Vanilla, also available with fiber)



Boost



(Mead Johnson)



17.44.31.7590-620CHO - Sucrose, corn syrup solids



Protein - Milk protein concentrate



Fat - Canola, sunflower, corn oils



(Chocolate, chocolate mocha, strawberry, vanilla)